Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
59
datasets available to search
ShareScore release 0.9.0
Dataset results
59 results for “post-transplant cyclophosphamide”
BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
ClinicalTrials.gov study NCT02029638. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT02120157. IPD Sharing: NO. Countries: 2. Publications: 1.
Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant
ClinicalTrials.gov study NCT01244906. IPD Sharing: Not stated. Countries: 1. Publications: 21.
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
ClinicalTrials.gov study NCT06828796. IPD Sharing: YES. Countries: 1. Publications: 10.
Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to
ClinicalTrials.gov study NCT02300571. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas
ClinicalTrials.gov study NCT02049580. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
ClinicalTrials.gov study NCT03910452. IPD Sharing: NO. Countries: 1. Publications: 3.
Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML
ClinicalTrials.gov study NCT03654703. IPD Sharing: NO. Countries: 1. Publications: 3.
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
ClinicalTrials.gov study NCT02828592. IPD Sharing: NO. Countries: 1. Publications: 9.
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
ClinicalTrials.gov study NCT02861417. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
ClinicalTrials.gov study NCT02996773. IPD Sharing: Not stated. Countries: 1. Publications: 5.
High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
ClinicalTrials.gov study NCT03945591. IPD Sharing: YES. Countries: 1. Publications: 0.
Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia
ClinicalTrials.gov study NCT03687463. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplan
ClinicalTrials.gov study NCT03192397. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
ClinicalTrials.gov study NCT01282216. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis
ClinicalTrials.gov study NCT01860170. IPD Sharing: NO. Countries: 1. Publications: 0.
Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide
ClinicalTrials.gov study NCT00800839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
ClinicalTrials.gov study NCT01010217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
ClinicalTrials.gov study NCT02999854. IPD Sharing: NO. Countries: 13. Publications: 0.
Signatures of GVHD and Relapse after Post-Transplant Cyclophosphamide Revealed by Immune Profiling and Machine Learning [15065R]
GEO Series GSE182610. Homo sapiens. 37 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.